Drug Trial Radar · NCT03043651
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
Last checked: Nov 20, 2026Latest source record: Oct 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
48
Actual
Start
Jan 30, 2018
Primary completion
Mar 2, 2020
Study completion Mar 2, 2020
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was an open-label study to evaluate the safety of continued therapy with oral treprostinil in subjects who completed Study TDE-HF-301. This study provided long-term, open-label data regarding the effect of continued long-term oral treprostinil therapy for the treatment of pulmonary hypertension (PH) associated with heart failure with preserved ejection fraction (HFpEF). Subject visits occurred at Baseline, Weeks 6, 12, 18, 24, and every 12 weeks thereafter until either oral treprostinil was commercially available to treat PH associated with HFpEF or the study was discontinued by the Sponsor. The Sponsor terminated Studies TDE-HF-301 and TDE-HF-302 on 14 October 2019 due to slow enrollment. Safety data from the final subject in Study TDE-HF-302 were recorded on 02 March 2020. Due to the lower than expected number of subjects enrolled, the planned secondary efficacy-related endpoints were not analyzed.
Conditions
- Pulmonary Hypertension Associated With HFpEF
Interventions
Oral treprostinilDrug
Sustained-release oral tablets for TID administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Long-term Safety of Oral Treprostinil in Subjects With PH Associated With HFpEF for Subjects Who Completed Study TDE-HF-301Time frame: Baseline through study completion, up to approximately 25 months
Locations
82 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner University Medical Center Phoenix
Phoenix, Arizona
University of Arizona
Tucson, Arizona
VA Healthcare System of Greater Los Angeles
Los Angeles, California
University of California Los Angeles Pulmonary Division
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
University of California - Davis Medical Center
Sacramento, California
Santa Barbara Cottage Hospital
Santa Barbara, California
Aurora Denver Cardiology Associates
Aurora, Colorado
University of Colorado Denver
Aurora, Colorado
National Jewish Health
Denver, Colorado
South Denver Cardiology
Littleton, Colorado
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Medical Faculty Associates, George Washington University
Washington D.C., District of Columbia
Bay Area Cardiology Associates
Brandon, Florida
Mayo Clinic - Jacksonville
Jacksonville, Florida
St. Vincent's Lung, Sleep, and Critical Care Specialists
Jacksonville, Florida
Central Florida Pulmonary Group, P.A.
Orlando, Florida
Florida Hospital
Orlando, Florida
University of South Florida ; Tampa General Hospital
Tampa, Florida
Cleveland Clinic of Florida
Weston, Florida
Emory University Hospital
Atlanta, Georgia
Augusta University
Augusta, Georgia
Piedmont Physicians Georgia Lung
Austell, Georgia
WellStar Medical Group
Marietta, Georgia
University of Illinois at Chicago Hospital
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
Advocate Christ Medical Center
Oak Lawn, Illinois
OSF HealthCare
Peoria, Illinois
Indiana University Health Methodist Research Institute, INC
Indianapolis, Indiana
Community Heart and Vascular Hospital
Indianapolis, Indiana
Saint Vincent Hospital and Health Services
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Iowa Heart Center
West Des Moines, Iowa
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky Medical Center
Lexington, Kentucky
Kentuckiana Pulmonary Associates
Louisville, Kentucky
University of Louisville Physicians Outpatient Center
Louisville, Kentucky
Chest Medicine Associates
South Portland, Maine
Tufts Medical Center
Boston, Massachusetts
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.